Hoya Surgical Optics has obtained European CE Mark for the Vivinex IOL with the new multiSert 4-in-1 preloaded delivery system. MultiSert offers cataract surgeons control in the palm of their hands as they now have the option of using either a two-handed screw or a one-handed technique while implanting the IOL. Additionally, multiSert comes with a uniquely-designed insert shield that allows the user to either implant the IOL directly into the capsular bag or through the incision tunnel, when the insert shield is advanced, according to Hoya.
The new device will be presented at the upcoming 36th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) taking place from September 22 to 26, 2018 in Vienna, Austria.
Depending on the surgeon’s preference and technique, multiSert allows for either a two-handed screw or a one-handed push implantation of an IOL. This offers surgeons a high level of flexibility and control when implanting the IOL into a patient’s eye. Usability assessments by cataract surgeons confirm that multiSert offers outstanding performance in controlled delivery and release among other similar products in the market.
The new multiSert will be introduced on Hoya’s flagship premier product platform, Vivinex. With close to 1 million Vivinex IOLs implanted, it is now the most proven new IOL material platform in the world. It is made of a glistening-free, hydrophobic acrylic material with a unique, proprietary active oxygen processing treatment to significantly reduce posterior capsule opacification (PCO).
“The perfect combination of our new multiSert preloaded delivery system and our premier flagship Vivinex IOL brings together the best of both worlds to surgeons and patients alike – offering unprecedented clarity of vision complemented by unrivalled control in the palm of the surgeon’s hands,” John Goltermann Lassen, Chief Executive Officer of Hota Surgical Optics, said in a company news release. “We truly believe that the Vivinex multiSert will be a game changer in the preloaded IOL delivery system space.”
Vivinex multiSert is expected to be commercially available to cataract surgeons in selected countries beginning September 2018. It will be available in clear and yellow lenses.
Learn more at the Hoya Surgical Optics booth #B209 at ESCRS.